SRX Global Inc is an AI-driven platform focused on investing in operating companies, strategic assets, and technology-enabled opportunities across multiple sectors. It uses technology and data analytics to identify and manage investments.
Last trade$0.8834
Day change-$0.0481 (-5.16%)
Day range$0.876 – $0.957
Volume256,917
Market cap$19M
OpenXASE
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$18.85M
Price / earnings
—
Price / book
0.13×
Price / sales
1.96×
EV / sales
-1.7×
EV / EBITDA
1.39×
Profitability
Earnings per share
-$0.94
Return on assets
-13.16%
Return on equity
-13.38%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0×
Current ratio
27.55×
Quick ratio
26.45×
Cash ratio
14.86×
Cash flow
Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$2.9M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for SRXH, quarterly periods
Line item
Q3 FY2026 Jun 30, 2026
Q2 FY2026 Mar 31, 2026
Q1 FY2026 Dec 31, 2025
Q4 FY2025 Sep 30, 2025
Q3 FY2025 Jun 30, 2025
Revenue
$3.39M
$3.44M
$2.81M
—
$2.67M
Cost of revenue
$2.49M
$2.16M
$1.75M
$0
$2.64M
Gross profit
$904K
$1.28M
$1.05M
—
$31K
Selling, general and administrative
$4.11M
$3.09M
$4.84M
—
$8.64M
Research and development
$0
$0
$0
—
$0
Total operating expenses
$4.11M
$3.09M
$4.84M
—
$8.64M
Operating income
-$3.2M
-$1.82M
-$3.79M
—
-$8.61M
Interest expense
-$569K
-$1.78M
-$1.29M
—
$30K
Income before taxes
-$4.14M
-$6.38M
-$8.61M
—
-$6.85M
Income taxes
$0
$2K
$4K
—
$0
Net income
-$4.14M
-$6.38M
-$8.61M
—
-$15.13M
Net income attributable to common shareholders
-$4.14M
-$6.38M
-$8.61M
—
-$15.13M
EBITDA
-$3.19M
-$1.89M
-$3.78M
-$2.89M
-$10.11M
Basic earnings per share
-$0.36
-$1.20
-$15.60
—
-$44.51
Diluted earnings per share
-$0.36
-$1.20
-$15.60
—
-$44.51
Recent news
Company coverage with links to the original publishers.
SRX Global Inc. announced a definitive agreement to acquire CERo Therapeutics Holdings, Inc., an innovative cellular immunotherapy company developing CER-1236 for hematologic malignancies. The acquisition will be structured through a wholly-owned SPV (CERO 1236) to avoid diluting existing SRX shareholders. The transaction is expected to accelerate CER-1236's clinical development and provide CERo with enhanced access to capital and operational resources. CERo has treated six patients in its Phase 1 CERTAIN-T trial with no dose-limiting toxicities observed at increased dose levels.
SRx Health Solutions has completed its acquisition of EMJ Crypto Technologies (EMJX) and rebranded as SRX Global Inc. The company is launching an AI-driven platform strategy focused on capital allocation into high-conviction operating companies and assets. The merged entity will be led by Kent Cunningham as CEO and Eric Jackson as President and Head of Asset Management, with initial investments in companies including Astro Capital, Opendoor Technologies, Uber Technologies, and Optimi Health Corp.
SRx Health Solutions (NYSE: SRXH) has acquired a 4.99% stake in Smartkem, Inc. (NASDAQ: SMTK), a leader in advanced materials, through a shelf take down. The company also purchased convertible preferred securities in a non-brokered private placement. This acquisition comes as SRx Health Solutions is in the process of merging with EMJ Crypto Technologies (EMJX).
SRx Health Solutions' board approved a plan to dividend 75% of profits from its investment in Astro Investment XVII, a special purpose vehicle with stakes in SpaceX and AI/space companies. The company, which is merging with EMJ Crypto Technologies, invested over 10% of its investable capital in the SPV and will return capital to shareholders upon wind down.
SRx Health Solutions (SRXH) announced the acquisition of shares in Compass Inc. and increased its investment in Opendoor Technologies Inc. The company also filed a Form S-4 with the SEC regarding its proposed merger with EMJ Crypto Technologies (EMJX). SRXH reported approximately 3.5% gains in its hedging pool and 8% gains in long treasury investments through mid-April.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
Ex-dividend
Amount / share
Pay date
Type
Jul 22, 2026
$0.05
Aug 3, 2026
special
Stock splits
Historical share-structure events and their execution dates.